[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
[ Tue, Mar 07th 2023 ]: WOPRAI
Paul Choi Maintained (BBIO) at Strong Buy with Increased Target to $28 on, Mar 7th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Paul Choi of Goldman Sachs, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $20 to $28 on, Mar 7th, 2023.
Paul has made no other calls on BBIO in the last 4 months.
There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Paul's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Paul
- Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Monday, February 6th, 2023
- Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $19 on, Monday, January 23rd, 2023